Evidence map›Paper›PMID 33839946›Full record

ArticleNeurosurgical review2021

The long-term outcome of CyberKnife-based stereotactic radiotherapy for central skull base meningiomas: a single-center experience.

Sukwoo Hong, Kengo Sato, Kenji Kagawa, Shunsuke Ichi

Abstract read
PubMed Publisher
In one paragraph

Article in Neurosurgical review, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
0.5field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 5 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Sukwoo HongDepartment of Neurosurgery, Japanese Red Cross Medical Center, 4-1-22 Hiroo, Shibuya City, Tokyo, 150-8935, Japan. honsohkaisei6031@gmail.com.ORCID http://orcid.org/0000-0002-3664-9245
Kengo SatoDepartment of Neurosurgery, Japanese Red Cross Medical Center, 4-1-22 Hiroo, Shibuya City, Tokyo, 150-8935, Japan.
Kenji KagawaDepartment of Neurosurgery, Japanese Red Cross Medical Center, 4-1-22 Hiroo, Shibuya City, Tokyo, 150-8935, Japan.
Shunsuke IchiDepartment of Neurosurgery, Japanese Red Cross Medical Center, 4-1-22 Hiroo, Shibuya City, Tokyo, 150-8935, Japan.
Japanese Red Cross Medical Center · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Few reports exist demonstrating the effects of stereotactic radiotherapy (SRT) on the central skull base meningiomas (CSMs). A retrospective analysis of 113 patients was performed. The median age was 62 (IQR 50-72) years old, and 78 patients (69%) were female. Upfront SRT was performed in 41 (36%), where 17 (15%) patients were asymptomatic. The other SRT was for postoperative adjuvant therapy in 32 (28%), and for the recurrent or relapsed tumors in 40 (35%) patients. Previous operation was done in 74 patients (66%). Among the available pathology in 46 patients, 37 (80%) were WHO grade I, 8 (17%) were grade II, and 1 (2%) was grade III. The median prescribed dose covered 95% of the planning target volume was 25 (IQR 21-25) Gy, and the median target volume was 9.5 (IQR 3.9-16.9) cm

Indexed as

Meningeal NeoplasmsMeningiomaRadiosurgerySkull Base NeoplasmsAgedFemaleFollow-Up StudiesHumansMiddle AgedRetrospective StudiesSkull BaseTreatment OutcomeCyberKnifeMeningiomaParasellarSkull base

Identifiers

PMID33839946
OpenAlexW3155510796

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.